A dynamical perspective of CTL cross-priming and regulation: Implications for cancer immunology

Immunology Letters

Volumn 86, Issue 3, 2003, Pages 213-227

  Wodarz, Dominik ^a   Jansen, Vincent A A ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

APC; Cancer; Cross Priming; CTL; Danger; Immunology; Self non self; Tolerance

Indexed keywords

ANTIGEN PRESENTATION; ARTICLE; CANCER GROWTH; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGICAL PARAMETERS; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; MATHEMATICAL MODEL; PRIORITY JOURNAL; REGULATORY MECHANISM; VACCINATION;

EID: 0037403611     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(03)00023-3     Document Type: Article

References (39)

1. Heath W.R., Carbone F.R. Nat. Rev. Immunol. 1:2001;126-134.
2. Heath W.R., Carbone F.R. Annu. Rev. Immunol. 19:2001;47-64.
3. Belz G.T., Vremec D., Febbraio M., Corcoran L., Shortman K., Carbone F.R., Heath W.R. J. Immunol. 168:2002;6066-6070.
4. Blankenstein T., Schuler T. Trends Immunol. 23:2002;171-173.
5. Albert M.L., Sauter B., Bhardwaj N. Nature. 392:1998;86-89.
6. Albert M.L., Jegathesan M., Darnell R.B. Nat. Immunol. 2:2001;1010-1017.
7. den Haan J.M., Lehar S.M., Bevan M.J. J. Exp. Med. 192:2000;1685-1696.
8. den Haan J.M., Bevan M.J. Curr. Opin. Immunol. 13:2001;437-441.
9. Banchereau J., Steinman R.M. Nature. 392:1998;245-252.
10. Dhodapkar M.V., Steinman R.M., Sapp M., Desai H., Fossella C., Krasovsky J., Donahoe S.M., Dunbar P.R., Cerundolo V., Nixon D.F., Bhardwaj N. J. Clin. Invest. 104:1999;173-180.
11. Dhodapkar M.V., Krasovsky J., Steinman R.M., Bhardwaj N. J. Clin. Invest. 105:2000;R9-R14.
12. Matzinger P. Semin. Immunol. 10:1998;399-415.
13. Matzinger P. Science. 296:2002;301-305.
14. Gallucci S., Matzinger P. Curr. Opin. Immunol. 13:2001;114-119.
15. Fuchs E.J., Matzinger P. Semin. Immunol. 8:1996;271-280.
16. Baumann S., Krueger A., Kirchhoff S., Krammer P.H. Curr. Mol. Med. 2:2002;257-272.
17. Hildeman D.A., Zhu Y., Mitchell T.C., Kappler J., Marrack P. Curr. Opin. Immunol. 14:2002;354-359.
18. Budd R.C. Curr. Opin. Immunol. 13:2001;356-362.
19. Guilloux Y., Bai X.F., Liu X., Zheng P., Liu Y. Cancer Res. 61:2001;1107-1112.
20. De Boer R.J., Perelson A.S. J. Theor. Biol. 175:1995;567-576.
21. Janeway C.A. Jr. Annu. Rev. Immunol. 20:2002;1-28.
22. Janeway C.A. Jr., Goodnow C.C., Medzhitov R. Curr. Biol. 6:1996;519-522.
23. Janeway C.A. Jr. Immunol. Res. 19:1999;107-118.
24. Medzhitov R., Janeway C.A. Jr. Semin. Immunol. 12:2000;185-188. discussion 257-344.
25. Loeb L.A. Cancer Res. 61:2001;3230-3239.
26. Wang E., Phan G.Q., Marincola F.M. Expert Opin. Biol. Ther. 1:2001;277-290.
27. Zhou Y., Bosch M.L., Salgaller M.L. J. Immunother. 25:2002;289-303.
28. Lehmann-Grube F. Virol. Monogr. 10:1971;1-173.
29. Thomsen A.R., Nansen A., Andreasen S.O., Wodarz D., Christensen J.P. Philos. Trans. R. Soc. London Ser. B. 355:2000;1031-1041.
30. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., Robbins G.K., D'Aquila R.T., Goulder P.J., Walker B.D. Nature. 407:2000;523-526.
31. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., Walker B.D. J. Exp. Med. 191:2000;1499-1512.
32. Kirn D.H., McCormick F. Mol. Med. Today. 2:1996;519-527.
33. Raj K., Ogston P., Beard P. Nature. 412:2001;914-917.
34. Bangham C.R.M., Hall S.E., Jeffrey K.J.M., Vine A.M., Witkover A., Nowak M.A., Wodarz D., Usuku K., Osame M. Philos. Trans. R. Soc. London Ser. B. 354:1999;691-700.
35. Wodarz D., Nowak M.A., Bangham C.R.M. Immunol. Today. 20:1999;220-227.
36. Fujinami R.S. Trends Microbiol. 9:2001;377-381.
37. Rouse B.T., Deshpande S. Rev. Med. Virol. 12:2002;107-113.
38. Folkman J. Mol. Med. 1:1995;120-122.
39. Uhr J.W., Marches R. Semin. Cancer Biol. 11:2001;277-283.